9th and 10th of November 2024 in Abu Dhabi, UAE.
Consultant, Internal Medicine
Imperial College London Diabetes Centre
Abu Dhabi, UAE
Dr. Farhana Bin Lootah brings 19 years of experience as an internal medicine consultant, specialising in diabetes and endocrinology. She joined Imperial College London Diabetes Centre (ICLDC) in 2010 where she is also the Lead Physician of the Centre’s flagship Khaleej Al Arabi branch.
After obtaining a Membership from the Royal School of Physicians in 2012, Dr. Farhana completed her Masters of Science in Health Policy from Imperial College London in 2017. In 2021, she obtained her certificate in Advance Leadership Program followed by a certification in Artificial Intelligence in Healthcare from MIT in 2022.
Prior to joining ICLDC, Dr Farhana spent her early career in the Republic of Ireland in ambulatory health services, developing an interest in medicine of the elderly, diabetes, obesity, disease prevention and public health awareness.
Dr. Farhana has been involved with several governmental programs and events for the Department of Health – Abu Dhabi and the Ministry of Health and Prevention – UAE. She is currently a faculty member and lecturer at ICLDC, administering the Imperial Diabetes Educator Training Course. Dr Farhana is also part of the Non-Alcoholic Steatohepatitis (NASH) global steering committee for the policy around NASH in Europe and the Middle East. She is a recipient of numerous awards and accolades including the Best Health Tips by Gulf Region Awards and the ICLDC CEO Award in 2020 for her pivotal role in leading the successful roll out of the home phlebotomy and medication delivery service during the Covid-19 pandemic. Her efforts and contribution as a healthcare front liner during the pandemic was also recognised by the Department of Health, Abu Dhabi.
Professor of Endocrinology,
Imperial College London, UK
Professor Karim Meeran did his undergraduate and postgraduate training in London, and then proceeded to an academic career at Imperial College. He is a Fellow both of the Royal College of Physicians and the Royal College of Pathologists. He is the Training Programme Director for Metabolic Medicine and Endocrinology in London and sits on the Education Committee for the European Society of Endocrinology.
He has over 100 peer reviewed articles and has published on Cushing’s syndrome, pituitary diseases, and the replacement of patients with pituitary and adrenal failure with glucocorticoids.
He is running an International study to compare low dose (3mg) prednisolone once daily with hydrocortisone three times daily in the search for a replacement that will avoid the need for emergency treatment of hypoadrenalism. Participants are welcome to join and details are on http://www.imperialendo.com/prednisolone-research